High risk of sensitization after failed islet transplantation

American Journal of Transplantation

Volumn 7, Issue 10, 2007, Pages 2311-2317

  Campbell, P M ^a,b   Senior, P A ^a   Salam, A ^a   LaBranche, K ^a   Bigam, D L ^a   Kneteman, N M ^a   Imes, S ^a   Halpin, A ^b   Ryan, E A ^a   Shapiro, A M J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Graft outcome; HLA antibodies; Islet transplant

Indexed keywords

ALEMTUZUMAB; ANTIBODY; DACLIZUMAB; DONOR SPECIFIC ANTIBODY; ETANERCEPT; HLA ANTIBODY; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SCREENING; ARTICLE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SENSITIZATION;

C-PEPTIDE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNIZATION; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIBODIES; T-LYMPHOCYTES; TREATMENT FAILURE;

EID: 34548301634     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01923.x     Document Type: Article

References (18)

1. Ryan EA, Paty BW, Senior PA et al. Five year follow up after clinical islet transplantation. Diabetes 2005 54 : 2060 2067.
2. Mao Q, Terasaki PI, Cai J, El-Awar N, Rebellato L. Analysis of HLA class I specific antibodies in patients with failed allografts. Transplantation 2007 83 : 54 61.
3. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003 3 : 665 673.
4. Smith RN, Kawai T, Boskovic S et al. Chronic antibody mediated rejection of renal allografts: Pathological serological and immunologic features in nonhuman primates. Am J Transplant 2006 6 : 1790 1798.
5. Regele H, Bohmig G, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
6. Campbell P, Salam A, Ryan E et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007 7 : 1242 1248.
7. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifel G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003 76 : 395 400.
8. Mohanakumar T, Waldrep JC, Phibbs M, Mendez-Picon G, Kaplan AM, Lee HM. Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 1981 32 : 61 66.
9. Cai J, Terasaki PI, Mao Q et al. Development of nondonor-specific HLA DR antibodies in allograft recipients is associated with shared epitopes with mismatch donor DR antigens. Am J Transplant 2006 6 : 2947 2954.
10. El-Awar N, Lee Jar-How, Tarsitani C, Terasaki P. HLA class I epitopes: Recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Human Immunol 2007 68 : 170 180.
11. Terasaki PI, Ozawa M, Castro R. Four Year Follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007 7 : 408 415.
12. Olack BJ, Swanson KS, Flavin KS et al. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 1997 29 : 2268 2269.
13. Mohanakumar T, Narayanan K, Desai N et al. A significant role for histocompatibility in human islet transplantation. Transplantation 2006 82 : 180 187.
14. Roep BO, Stobbe I, Duinkerken G et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type I diabetic patients. Diabetes 1999 48 : 484 490.
15. Dankers MKA, Witvliet MD, Roelen DL et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched HLA antigens. Transplantation 2004 128 : 1236.
16. Duquesnoy R. A structurally based approach to determine HLA compatibility at the humoral immune level. Human Immunol 2006 67 : 847 862.
17. Adeyi OA, Girnita AL, Howe J et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transplant Immunol 2005 14 : 53 62.
18. Adams A, Shirasugi N, Jones T et al. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 2005 174 : 542 550.